NP
Naseem Padaria Shoaib
About Naseem Padaria Shoaib
Naseem Padaria Shoaib has 18 years in corporate governance. Holds Designated Partner and Director roles. Currently with 3 companies, including Dr. House Cardiovascular Center Llp and Dr. Padaria's Medical Consultancy Services Llp. Formerly with 2 companies. Engaged in General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Dr. House Cardiovascular Center Llp
AAS-9018
|
Designated Partner | 15 Jul 2020 | 2020 | Active |
| Designated Partner | 23 Oct 2017 | 2017 | Active | |
| Designated Partner | 10 Apr 2019 | 2019 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
|
Hbot Solutions India Private Limited
U55209MH2007PTC168906
|
Director | 09 May 2008 | 2007 | Strike Off |
|
Citadel Cardiovascular Centre Private Limited
U74999MH2015PTC271302
|
Director | 23 Dec 2015 | 2015 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Naseem Padaria Shoaib
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Naseem Padaria Shoaib
Naseem Padaria Shoaib has 18 years in corporate governance. Holds Designated Partner and Director roles. Currently with 3 companies, including Dr. House Cardiovascular Center Llp and Dr. Padaria's Medical Consultancy Services Llp. Formerly with 2 companies. Engaged in General Business. Contributes to corporate operations.
Naseem Padaria Shoaib is associated with 3 companies as Designated Partner and Director.
Naseem Padaria Shoaib has expertise in General Business.
Naseem Padaria Shoaib has 18 years in corporate governance.